Evaluation of Nitazoxanide for the Treatment of Disseminated Cystic Echinococcosis: Report of Five Cases and Literature Review
Authors:
- José A. Pérez-MolinaJPJosé A. Pérez-Molina
- Marta Díaz-MenéndezMDMarta Díaz-Menéndez
- José I. GallegoJGJosé I. Gallego
- Francesca NormanFNFrancesca Norman
- Begoña Monge-MailloBMBegoña Monge-Maillo
- Ana Pérez AyalaAAAna Pérez Ayala
- Rogelio López-VélezRLRogelio López-Vélez
- 4 February 2011
- journal article
- case report
- Published by American Society of Tropical Medicine and Hygiene in The American Journal of Tropical Medicine and Hygiene
- Vol. 84 (2) , 351-356
Abstract
We aimed to evaluate the effectiveness of nitazoxanide in disseminated cystic echinococcosis (DCE) that failed to respond to surgical and antiparasitic therapy. We report on seven patients (five of them with bony involvement): two cases from the literature and five patients who were included in a compassionate trial of nitazoxanide therapy in our hospital. Median follow-up time until nitazoxanide therapy was 12 years and all patients had received prior medical treatment and extensive surgery. Nitazoxanide (500 mg/12 h) in combination with albendazole, with/without praziquantel, was administered for 3–24 months. Three patients improved: one with muscle involvement (clinico-radiological response), one with lung involvement (radiological response), and another with soft tissue and bony involvement (clinico-radiological response of soft tissue cysts). There was one discontinuation after 15 days of starting therapy. Nitazoxanide combination therapy could have a role in the treatment of DCE when there is no bony involvement. Long-term safety profile seems to be favorable.Keywords
This publication has 36 references indexed in Scilit:
- Update on cystic hydatid diseaseCurrent Opinion in Infectious Diseases, 2009
- Treatment Response of Cystic Echinococcosis to Benzimidazoles: A Systematic ReviewPLOS Neglected Tropical Diseases, 2009
- Clinical trial: randomized, double‐blind, placebo‐controlled study of nitazoxanide monotherapy for the treatment of patients with chronic hepatitis C genotype 4Alimentary Pharmacology & Therapeutics, 2008
- The effect of combination therapy with albendazole and praziquantel on hydatid cyst treatmentParasitology Research, 2008
- NitazoxanideDrugs, 2007
- In Vitro Activities of Itraconazole, Methiazole, and Nitazoxanide versus Echinococcus multilocularis LarvaeAntimicrobial Agents and Chemotherapy, 2006
- Nitazoxanide, a broad-spectrum thiazolide anti-infective agent for the treatment of gastrointestinal infectionsExpert Opinion on Pharmacotherapy, 2006
- Secondary and primary murine alveolar echinococcosis: combined albendazole/nitazoxanide chemotherapy exhibits profound anti-parasitic activityInternational Journal for Parasitology, 2004
- Albendazole for the treatment of echinococcosisFundamental & Clinical Pharmacology, 2003
- In Vitro Parasiticidal Effect of Nitazoxanide against Echinococcus multilocularis MetacestodesAntimicrobial Agents and Chemotherapy, 2003